Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United Surgical Partners International
Providers
Tenet CEO says pandemic volume recovery on its last legs
High acuity and per case net revenue trumps volume chasing for Tenet, though executives say there's still room for both within the hospital segment.
Dave Muoio
May 14, 2024 3:00pm
Tenet increases FY24 guidance by $215M, touts Q1 performance
Apr 30, 2024 1:30pm
Tenet sees $123M profit in Q2 on 'robust' ASC, inpatient volumes
Jul 31, 2023 6:57pm
Tenet Healthcare logs $143M Q1 profit, raises FY2023 guidance
Apr 25, 2023 12:54pm
Tenet lowers 2022 outlook for USPI after Hurricane Ian
Oct 21, 2022 1:48pm
ASC business shielded Tenet from COVID labor crunch, execs say
May 11, 2022 7:25am
